首页> 外国专利> ORAL COMPOSITION, INCLUDING 3- 5- 4- (CYCLOPENTYLOXY) -2-HYDROXYBENZOYL -2 - (3-HYDROXY-1,2-BENZISOXAZOL-6- YL) METHOXYPHENYLPROPIONIC ACID OR SALT THEREOF

ORAL COMPOSITION, INCLUDING 3- 5- 4- (CYCLOPENTYLOXY) -2-HYDROXYBENZOYL -2 - (3-HYDROXY-1,2-BENZISOXAZOL-6- YL) METHOXYPHENYLPROPIONIC ACID OR SALT THEREOF

机译:口服组合物,包括3- [5- [4-(环戊基)-2-羟基苯甲酰基] -2-](3-羟基-1,2-苯异恶唑-6-基)甲氧基苯丙酸或盐

摘要

An oral composition contains 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propionic acid or a salt thereof and polyvinylpyrrolidone is advantageous as an oral medication composition (1) which can be produced without requiring new manufacturing equipment; (2) which can be produced with simple steps; (3) which maintains stable solubility even with changes in the pH of the gastrointestinal tract and of which gastrointestinal tract absorption is improved.
机译:口服组合物包含3- {5- [4-(环戊氧基)-2-羟基苯甲酰基] -2-[(3-羟基-1,2-苯并恶唑-6-基)甲氧基]苯基}丙酸或其盐,和聚乙烯吡咯烷酮作为口服药物组合物(1)是有利的,它可以不需要新的生产设备即可生产; (2)可以通过简单的步骤生产; (3)即使在胃肠道的pH值变化时也能保持稳定的溶解度,并且改善了胃肠道的吸收。

著录项

  • 公开/公告号DK2022497T3

    专利类型

  • 公开/公告日2014-05-19

    原文格式PDF

  • 申请/专利权人 TOYAMA CHEMICAL CO. LTD.;

    申请/专利号DK20070744105T

  • 申请日2007-05-25

  • 分类号A61K31/423;A61K9;A61K9/08;A61K9/16;A61K9/20;A61K9/48;A61K47/02;A61K47/18;A61K47/32;A61P29;

  • 国家 DK

  • 入库时间 2022-08-21 15:58:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号